To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxin, synthetic fibers, chemical fragrances, and other components of feminine hygiene products.
USA115th CongressHR-2379| House
| Updated: 5/5/2017
Carolyn B. Maloney
Democratic Representative
New York
Cosponsors (8)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Robin Danielson Feminine Hygiene Product Safety Act of 2017 This bill amends the Public Health Service Act to require the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in feminine hygiene products pose health risks to women who use the products or to the children of women who use the products during or before pregnancy.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
CancerChild healthHazardous wastes and toxic substancesHealth programs administration and fundingHealth technology, devices, suppliesHereditary and development disordersImmunology and vaccinationInfectious and parasitic diseasesMedical researchProduct safety and qualitySex and reproductive healthWomen's health
To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxin, synthetic fibers, chemical fragrances, and other components of feminine hygiene products.
USA115th CongressHR-2379| House
| Updated: 5/5/2017
Robin Danielson Feminine Hygiene Product Safety Act of 2017 This bill amends the Public Health Service Act to require the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in feminine hygiene products pose health risks to women who use the products or to the children of women who use the products during or before pregnancy.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Carolyn B. Maloney
Democratic Representative
New York
Cosponsors (8)
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
CancerChild healthHazardous wastes and toxic substancesHealth programs administration and fundingHealth technology, devices, suppliesHereditary and development disordersImmunology and vaccinationInfectious and parasitic diseasesMedical researchProduct safety and qualitySex and reproductive healthWomen's health